Schwartz GK - Search Results

1

A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery.

Rosenbaum E, Chugh R, Ryan CW, Agulnik M, Milhem MM, George S, Jones RL, Chmielowski B, Van Tine BA, Tawbi H, Elias AD, Read WL, Budd GT, Qin LX, Rodler ET, Hirman J, Weiden P, Bennett CM, Livingston PO, Ragupathi G, Hansen D, D'Angelo SP, Tap WD, Schwartz GK, Maki RG, Carvajal RD. Rosenbaum E, et al. Among authors: schwartz gk. Eur J Cancer. 2022 Nov;176:155-163. doi: 10.1016/j.ejca.2022.09.003. Epub 2022 Oct 8. Eur J Cancer. 2022. PMID: 36215947 Free PMC article. Clinical Trial.

2

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.

Elias AD, Ayash L, Anderson KC, Hunt M, Wheeler C, Schwartz G, Tepler I, Mazanet R, Lynch C, Pap S, et al. Elias AD, et al. Blood. 1992 Jun 1;79(11):3036-44. Blood. 1992. PMID: 1350229 Free article.

3

GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: two protocols.

Elias AD, Mazanet R, Wheeler C, Anderson K, Ayash L, Schwartz G, Tepler I, Pap S, Pelaez J, Hunt M, et al. Elias AD, et al. Breast Cancer Res Treat. 1991 Dec;20 Suppl:S25-9. doi: 10.1007/BF01908241. Breast Cancer Res Treat. 1991. PMID: 1687204

4

The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.

Elias AD, Ayash L, Tepler I, Wheeler C, Schwartz G, Mazanet R, Schnipper L, Frei E 3rd, Antman K. Elias AD, et al. J Hematother. 1993 Fall;2(3):377-82. doi: 10.1089/scd.1.1993.2.377. J Hematother. 1993. PMID: 7522891 Clinical Trial.

5

Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.

Elias AD, Ayash LJ, Wheeler C, Schwartz G, Tepler I, Gonin R, McCauley M, Mazanet R, Schnipper L, Frei E 3rd, et al. Elias AD, et al. Bone Marrow Transplant. 1995 Mar;15(3):373-9. Bone Marrow Transplant. 1995. PMID: 7599561 Clinical Trial.

6

High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.

Elias AD, Ayash LJ, Wheeler C, Schwartz G, Tepler I, McCauley M, Mazanet R, Schnipper L, Frei E 3rd, Antman KH. Elias AD, et al. Semin Oncol. 1994 Oct;21(5 Suppl 12):83-5. Semin Oncol. 1994. PMID: 7992072 Clinical Trial.

7

High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancer.

Elias AD, Ayash L, Skarin AT, Wheeler C, Schwartz G, Mazanet R, Tepler I, Schnipper L, Frei E 3rd, Antman KH. Elias AD, et al. Chest. 1993 Apr;103(4 Suppl):433S-435S. doi: 10.1378/chest.103.4_supplement.433s. Chest. 1993. PMID: 8096454

8

Intensive combined modality therapy for limited-stage small-cell lung cancer.

Elias AD, Ayash L, Frei E 3rd, Skarin AT, Hunt M, Wheeler C, Schwartz G, Mazanet R, Tepler I, Eder JP, et al. Elias AD, et al. J Natl Cancer Inst. 1993 Apr 7;85(7):559-66. doi: 10.1093/jnci/85.7.559. J Natl Cancer Inst. 1993. PMID: 8384264 Clinical Trial.

9

Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma.

Casper ES, Christman KL, Schwartz GK, Johnson B, Brennan MF, Bertino JR. Casper ES, et al. Among authors: schwartz gk. Cancer. 1993 Aug 1;72(3):766-70. doi: 10.1002/1097-0142(19930801)72:3<766::aid-cncr2820720321>3.0.co;2-z. Cancer. 1993. PMID: 8392904 Clinical Trial.

10

Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.

Kortmansky J, Shah MA, Kaubisch A, Weyerbacher A, Yi S, Tong W, Sowers R, Gonen M, O'reilly E, Kemeny N, Ilson DI, Saltz LB, Maki RG, Kelsen DP, Schwartz GK. Kortmansky J, et al. Among authors: schwartz gk. J Clin Oncol. 2005 Mar 20;23(9):1875-84. doi: 10.1200/JCO.2005.03.116. Epub 2005 Feb 7. J Clin Oncol. 2005. PMID: 15699481 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

315 results

Search Page